Semler Scientific (SMLR) Competitors $61.78 +0.44 (+0.72%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SMLR vs. CNMD, TNDM, TMDX, SLNO, RXST, INMD, MDXG, ESTA, BLFS, and PLSEShould you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include CONMED (CNMD), Tandem Diabetes Care (TNDM), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), RxSight (RXST), InMode (INMD), MiMedx Group (MDXG), Establishment Labs (ESTA), BioLife Solutions (BLFS), and Pulse Biosciences (PLSE). These companies are all part of the "medical equipment" industry. Semler Scientific vs. CONMED Tandem Diabetes Care TransMedics Group Soleno Therapeutics RxSight InMode MiMedx Group Establishment Labs BioLife Solutions Pulse Biosciences CONMED (NYSE:CNMD) and Semler Scientific (NASDAQ:SMLR) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, valuation, media sentiment, profitability, institutional ownership, risk, dividends and earnings. Which has more risk and volatility, CNMD or SMLR? CONMED has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Do institutionals & insiders hold more shares of CNMD or SMLR? 49.4% of Semler Scientific shares are owned by institutional investors. 6.8% of CONMED shares are owned by company insiders. Comparatively, 30.2% of Semler Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is CNMD or SMLR more profitable? Semler Scientific has a net margin of 27.00% compared to CONMED's net margin of 10.23%. Semler Scientific's return on equity of 20.31% beat CONMED's return on equity.Company Net Margins Return on Equity Return on Assets CONMED10.23% 13.84% 5.26% Semler Scientific 27.00%20.31%18.78% Do analysts recommend CNMD or SMLR? CONMED presently has a consensus target price of $79.80, indicating a potential upside of 16.28%. Given CONMED's higher probable upside, equities analysts plainly believe CONMED is more favorable than Semler Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CONMED 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Semler Scientific 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Which has stronger valuation & earnings, CNMD or SMLR? CONMED has higher revenue and earnings than Semler Scientific. CONMED is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCONMED$1.29B1.65$64.46M$4.2116.30Semler Scientific$58.94M8.69$20.58M$2.0530.14 Does the MarketBeat Community favor CNMD or SMLR? CONMED received 33 more outperform votes than Semler Scientific when rated by MarketBeat users. However, 50.00% of users gave Semler Scientific an outperform vote while only 47.22% of users gave CONMED an outperform vote. CompanyUnderperformOutperformCONMEDOutperform Votes3447.22% Underperform Votes3852.78% Semler ScientificOutperform Votes150.00% Underperform Votes150.00% Does the media favor CNMD or SMLR? In the previous week, Semler Scientific had 6 more articles in the media than CONMED. MarketBeat recorded 7 mentions for Semler Scientific and 1 mentions for CONMED. CONMED's average media sentiment score of 1.63 beat Semler Scientific's score of 0.51 indicating that CONMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Semler Scientific 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummarySemler Scientific beats CONMED on 11 of the 19 factors compared between the two stocks. Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Get Semler Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMLR vs. The Competition Export to ExcelMetricSemler ScientificElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$512.09M$3.01B$5.06B$9.08BDividend YieldN/A1.75%4.84%4.21%P/E Ratio30.1416.15102.6717.15Price / Sales8.6950.121,121.74116.80Price / Cash21.8039.9141.3037.88Price / Book5.913.724.744.78Net Income$20.58M$89.83M$119.11M$225.60M7 Day Performance-8.02%-1.82%-1.86%-1.21%1 Month Performance-5.87%0.28%11.37%3.09%1 Year Performance40.54%4.10%30.22%16.48% Semler Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMLRSemler Scientific1.3135 of 5 stars$61.78+0.7%N/A+44.1%$572.54M$58.94M30.1492Gap UpCNMDCONMED4.6156 of 5 stars$71.57-1.4%$79.80+11.5%-36.7%$2.21B$1.29B17.234,000Positive NewsTNDMTandem Diabetes Care4.6387 of 5 stars$33.09+1.3%$53.81+62.6%+30.3%$2.17B$747.72M-16.922,400Positive NewsTMDXTransMedics Group4.0342 of 5 stars$63.72-0.8%$126.80+99.0%-20.1%$2.14B$241.62M68.36210Analyst ForecastSLNOSoleno Therapeutics4.4752 of 5 stars$48.55+3.9%$74.83+54.1%+25.5%$2.09BN/A-14.0730Positive NewsRXSTRxSight2.9587 of 5 stars$38.79+4.0%$62.13+60.2%-11.8%$1.56B$89.08M-46.59220Analyst DowngradeGap DownINMDInMode3.6286 of 5 stars$18.12-0.8%$22.60+24.7%-21.7%$1.52B$423.75M9.87480Positive NewsMDXGMiMedx Group2.8171 of 5 stars$9.50+3.7%$12.00+26.3%+1.7%$1.40B$342.80M16.65895ESTAEstablishment Labs2.5284 of 5 stars$46.74+1.6%$60.60+29.7%+73.3%$1.31B$153.07M-17.83960Positive NewsBLFSBioLife Solutions1.2686 of 5 stars$27.28+2.2%$28.29+3.7%+79.4%$1.27B$146.96M-25.19409Analyst ForecastInsider TradeNews CoverageGap DownPLSEPulse Biosciences1.8696 of 5 stars$20.21+14.5%N/A+56.3%$1.24B$700,000.000.00140Insider TradeNews CoveragePositive News Related Companies and Tools Related Companies CONMED Alternatives Tandem Diabetes Care Alternatives TransMedics Group Alternatives Soleno Therapeutics Alternatives RxSight Alternatives InMode Alternatives MiMedx Group Alternatives Establishment Labs Alternatives BioLife Solutions Alternatives Pulse Biosciences Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SMLR) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semler Scientific, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Semler Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.